logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Return

Recent developments in C3-targeted complement therapeutics

delete2022-03-01
delete3
PRE
AI
D
Dimitrios C. Mastellos *
J
John D. Lambris
DOI：10.1016/j.smim.2022.101645delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En
Keywords:
INHIBITOR
C3
DEFICIENCIES
COMPSTATIN
SYSTEM

Journal

Seminars in Immunology cover
Seminars in Immunology
IF:
7.8
Papers:
1.5K
Citations:
7.3K

Organization

U
university of pennsylvania
Scholars:
9.2W
Papers: 7.8W
Citations: 153
N
National Centre of Scientific Research Demokritos
Scholars:
4.4K
Papers: 3.9K
Citations: 3.3K